HIMSS May 13, 2020
Ben Taylor, CEO and Founder, LedgerDomain; a HIMSS Blockchain in Healthcare Task Force Member

Under the Drug Supply Chain Security Act (DSCSA), the U.S. pharmaceutical supply chain will be brought together by an electronic, interoperable system to identify and trace prescription drugs as they’re distributed throughout the country. This has radical implications for the entire industry, as regulators and stakeholders all race the clock to transform how drugs reach the patients who need them.

In today’s drug supply chain, DSCSA-compliant verification is rare; but once it becomes required, without a real-time system that allows for single scans and near-instant verification, pharmacies will bear a massive regulatory burden.

To address these needs, a peer-reviewed study was commissioned in partnership with UCLA Health to deploy and test a last-mile blockchain-driven solution for caregivers to use in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Blockchain, Pharma / Biotech, Supply Chain, Technology
The AI Software Supply Chain Is A Dumpster Fire: Here's What Companies Can Do About It
Supply chain challenges in 2025: 5 things to know
As Supply Chains Go Digital, Cybersecurity Must be Strongest Link
Digital twins: The key to unlocking end-to-end supply chain growth
Why Supply Chain Technology Keeps Failing—And How To Fix It

Share This Article